Atlas Trials

An Efficacy and Safety Study of AVR-RD-02 Compared to Enzyme Replacement Therapy for Treatment of Gaucher Disease Type 3

Clinical trial NCT05815004 · WITHDRAWN

Trial details

NCT number
NCT05815004
Sponsor
AVROBIO
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Gaucher Disease, Type 3
Start date
2023-10-01
Primary completion
2027-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.